Analysis set for each outcome and definition.
<div><p>Introduction</p><p>Neurologic or immune-mediated conditions have been evaluated as potential adverse events (AEs) in coronavirus disease 2019 (COVID-19) vaccine safety surveillance. To contextualize United States (US) surveillance findings, it is important to quantify...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , , , , , , , , , , , , , , , , |
| Publicado: |
2025
|
| Materias: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!